Retatrutide – 20mg

Retatrutide is a research peptide studied as a triple receptor agonist, meaning it activates the GLP-1, GIP, and glucagon receptors. This “triple incretin” activity sets it apart from other compounds such as semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP). By targeting three pathways at once, retatrutide is being investigated for its potential in weight management, metabolic regulation, and energy balance.

Retatrutide is provided strictly for laboratory and research purposes only.

Reta is a synthetic peptide supplied in a 10mg vial as a lyophilized powder. It is provided exclusively for laboratory-based, in vitro research applications. Reta has been studied in experimental models for its potential role in cellular and biochemical pathways under controlled research conditions.

Specifications:

Quantity: 20mg per vial

Purity: ≥99% (analytically verified)

Molecular Formula: C225H348N60O70

Molecular Weight: 4958.63 g/mol

Form: Lyophilized powder

Appearance: White/off-white powder

Grade: Research use only – not for human or veterinary use

Storage & Handling: Store dry at –20 °C. Avoid repeated freeze-thaw cycles

Reconstitute with bacteriostatic water or a suitable solvent for research protocols

Use appropriate PPE during handling

Important Notice: This product is intended for in vitro laboratory research use only. It is not intended for human consumption or for use in humans or animals. Buyer assumes all responsibility for proper handling and compliance with local regulations.

All batches are lab tested for identity and purity. COAs are available upon request.